395 related articles for article (PubMed ID: 29693227)
1. The relationship between tumour size, nodal status and distant metastases: on the origins of breast cancer.
Sopik V; Narod SA
Breast Cancer Res Treat; 2018 Aug; 170(3):647-656. PubMed ID: 29693227
[TBL] [Abstract][Full Text] [Related]
2. The correlation between tumor size, lymph node status, distant metastases and mortality in rectal cancer patients without neoadjuvant therapy.
Luo D; Shan Z; Liu Q; Cai S; Ma Y; Li Q; Li X
J Cancer; 2021; 12(6):1616-1622. PubMed ID: 33613748
[TBL] [Abstract][Full Text] [Related]
3. Staging of women with breast cancer after introduction of sentinel node guided axillary dissection.
Tvedskov TF
Dan Med J; 2012 Jul; 59(7):B4475. PubMed ID: 22759850
[TBL] [Abstract][Full Text] [Related]
4. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
5. Effect of lymph node metastasis size on breast cancer-specific and overall survival in women with node-positive breast cancer.
Rose BS; Jiang W; Punglia RS
Breast Cancer Res Treat; 2015 Jul; 152(1):209-216. PubMed ID: 26041688
[TBL] [Abstract][Full Text] [Related]
6. Axillary lymph node metastases in patients with small carcinomas of the breast: is accurate prediction possible?
Anan K; Mitsuyama S; Tamae K; Nishihara K; Iwashita T; Abe Y; Ihara T; Toyoshima S
Eur J Surg; 2000 Aug; 166(8):610-5. PubMed ID: 11003428
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Survival Outcomes Among Patients With Breast Cancer With Distant vs Ipsilateral Supraclavicular Lymph Node Metastases.
Pan H; Wang H; Qian M; Mao X; Shi G; Ma G; Yu M; Xie H; Ling L; Ding Q; Zhang K; Wang S; Zhou W
JAMA Netw Open; 2021 Mar; 4(3):e211809. PubMed ID: 33724394
[TBL] [Abstract][Full Text] [Related]
8. Correlation of tumor size and axillary lymph node involvement with prognosis in patients with T1 breast carcinoma.
Abner AL; Collins L; Peiro G; Recht A; Come S; Shulman LN; Silver B; Nixon A; Harris JR; Schnitt SJ; Connolly JL
Cancer; 1998 Dec; 83(12):2502-8. PubMed ID: 9874455
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic role of axillary lymph node dissection in patients with stage IV breast cancer: a population-based analysis.
Wu SG; Li FY; Chen Y; Sun JY; Lin HX; Lin Q; He ZY
J Cancer Res Clin Oncol; 2017 Mar; 143(3):467-474. PubMed ID: 27812853
[TBL] [Abstract][Full Text] [Related]
10. Biomarker expression and St Gallen molecular subtype classification in primary tumours, synchronous lymph node metastases and asynchronous relapses in primary breast cancer patients with 10 years' follow-up.
Falck AK; Bendahl PO; Chebil G; Olsson H; Fernö M; Rydén L
Breast Cancer Res Treat; 2013 Jul; 140(1):93-104. PubMed ID: 23807420
[TBL] [Abstract][Full Text] [Related]
11. Axillary tumour burden in women with a fine-needle aspiration/core biopsy-proven positive node on ultrasonography compared to women with a positive sentinel node.
Lloyd P; Theophilidou E; Newcombe RG; Pugh L; Goyal A
Br J Surg; 2017 Dec; 104(13):1811-1815. PubMed ID: 28991362
[TBL] [Abstract][Full Text] [Related]
12. The natural history of human breast cancer. The relationship between involvement of axillary lymph nodes and the initiation of distant metastases.
Koscielny S; Le MG; Tubiana M
Br J Cancer; 1989 May; 59(5):775-82. PubMed ID: 2736212
[TBL] [Abstract][Full Text] [Related]
13. The expression of p53, bcl-2, bax, fas and fasL in the primary tumour and lymph node metastases of breast cancer.
Sjöström-Mattson J; Von Boguslawski K; Bengtsson NO; Mjaaland I; Salmenkivi K; Blomqvist C
Acta Oncol; 2009; 48(8):1137-43. PubMed ID: 19863221
[TBL] [Abstract][Full Text] [Related]
14. Sentinel node biopsy is not sensible in breast cancer patients with large primary tumours.
Leidenius MH; Krogerus LA; Toivonen TS; von Smitten KA
Eur J Surg Oncol; 2005 May; 31(4):364-8. PubMed ID: 15837040
[TBL] [Abstract][Full Text] [Related]
15. Impact of axillary nodal metastases on lymphatic mapping and sentinel lymph node identification rate in patients with early stage breast cancer.
Pelosi E; Ala A; Bellò M; Douroukas A; Migliaretti G; Berardengo E; Varetto T; Bussone R; Bisi G
Eur J Nucl Med Mol Imaging; 2005 Aug; 32(8):937-42. PubMed ID: 15838690
[TBL] [Abstract][Full Text] [Related]
16. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases.
Carter CL; Allen C; Henson DE
Cancer; 1989 Jan; 63(1):181-7. PubMed ID: 2910416
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of clinical parameters influencing the development of bone metastasis in breast cancer.
Diessner J; Wischnewsky M; Stüber T; Stein R; Krockenberger M; Häusler S; Janni W; Kreienberg R; Blettner M; Schwentner L; Wöckel A; Bartmann C
BMC Cancer; 2016 May; 16():307. PubMed ID: 27175930
[TBL] [Abstract][Full Text] [Related]
18. The prevalence of axillary lymph-node metastases in patients with pure tubular carcinoma of the breast and sentinel node biopsy.
Leikola J; Heikkilä P; von Smitten K; Leidenius M
Eur J Surg Oncol; 2006 Jun; 32(5):488-91. PubMed ID: 16569494
[TBL] [Abstract][Full Text] [Related]
19. The effect of Paget disease on axillary lymph node metastases and survival in invasive ductal carcinoma.
Wong SM; Freedman RA; Sagara Y; Stamell EF; Desantis SD; Barry WT; Golshan M
Cancer; 2015 Dec; 121(24):4333-40. PubMed ID: 26376021
[TBL] [Abstract][Full Text] [Related]
20. [Very slight chance of other metastases in axillary nodes of breast cancer patients with a small sentinel node metastasis without extranodal tumor growth].
van der Loo EM; Hop WC; Tervoort MA; de Graaf PW
Ned Tijdschr Geneeskd; 2004 May; 148(19):938-43. PubMed ID: 15160561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
